Satoshi Shuto - Search Results

Year	Number of Results
1996	1
1997	1
1998	1
2002	11
2003	10
2004	6
2005	5
2006	9
2007	2
2008	5
2009	3
2010	4
2011	6
2012	10
2013	19
2014	9
2015	10
2016	11
2017	14
2018	12
2019	7
2020	10
2021	10
2022	8
2023	6
2024	0

1

Development of Conformationally Restricted Negamycin Derivatives for Potent Readthrough Activity.

Omura N, Taguchi A, Kuwahara T, Hamada K, Watanabe M, Nakakuki M, Konno S, Takayama K, Taniguchi A, Nomura T, Shuto S, Hayashi Y. Omura N, et al. Among authors: shuto s. ACS Med Chem Lett. 2023 Dec 4;14(12):1807-1814. doi: 10.1021/acsmedchemlett.3c00424. eCollection 2023 Dec 14. ACS Med Chem Lett. 2023. PMID: 38116427

2

Individual resolvin E family members work distinctly and in a coordinated manner in the resolution of inflammation.

Hamaguchi A, Fukuda H, Fujiwara K, Harada T, Fukushima K, Shuto S, Fujino H. Hamaguchi A, et al. Among authors: shuto s. Prostaglandins Other Lipid Mediat. 2023 Oct;168:106759. doi: 10.1016/j.prostaglandins.2023.106759. Epub 2023 Jun 14. Prostaglandins Other Lipid Mediat. 2023. PMID: 37327943

3

Two oxytocin analogs, N-(p-fluorobenzyl) glycine and N-(3-hydroxypropyl) glycine, induce uterine contractions ex vivo in ways that differ from that of oxytocin.

Cherepanov SM, Yuhi T, Iizuka T, Hosono T, Ono M, Fujiwara H, Yokoyama S, Shuto S, Higashida H. Cherepanov SM, et al. Among authors: shuto s. PLoS One. 2023 Feb 9;18(2):e0281363. doi: 10.1371/journal.pone.0281363. eCollection 2023. PLoS One. 2023. PMID: 36758056 Free PMC article.

4

Intranasal Administration of Resolvin E1 Produces Antidepressant-Like Effects via BDNF/VEGF-mTORC1 Signaling in the Medial Prefrontal Cortex.

Deyama S, Aoki S, Sugie R, Fukuda H, Shuto S, Minami M, Kaneda K. Deyama S, et al. Among authors: shuto s. Neurotherapeutics. 2023 Mar;20(2):484-501. doi: 10.1007/s13311-022-01337-1. Epub 2023 Jan 9. Neurotherapeutics. 2023. PMID: 36622634 Free PMC article.

5

Delivering mRNA to Secondary Lymphoid Tissues by Phosphatidylserine-Loaded Lipid Nanoparticles.

Gomi M, Sakurai Y, Sato M, Tanaka H, Miyatake Y, Fujiwara K, Watanabe M, Shuto S, Nakai Y, Tange K, Hatakeyama H, Akita H. Gomi M, et al. Among authors: shuto s. Adv Healthc Mater. 2023 Apr;12(9):e2202528. doi: 10.1002/adhm.202202528. Epub 2022 Dec 25. Adv Healthc Mater. 2023. PMID: 36535635

6

Helix-forming aliphatic homo-δ-peptide foldamers based on the conformational restriction effects of cyclopropane.

Nagata M, Watanabe M, Doi R, Uemura M, Ochiai N, Ichinose W, Fujiwara K, Sato Y, Kameda T, Takeuchi K, Shuto S. Nagata M, et al. Among authors: shuto s. Org Biomol Chem. 2023 Feb 1;21(5):970-980. doi: 10.1039/d2ob01715f. Org Biomol Chem. 2023. PMID: 36426637

7

Development of potent non-acylhydrazone inhibitors of intestinal sodium-dependent phosphate transport protein 2b (NaPi2b).

Maemoto M, Hirata Y, Hosoe S, Ouchi J, Uchii M, Takada H, Akizawa E, Yanagisawa A, Shuto S. Maemoto M, et al. Among authors: shuto s. Bioorg Med Chem. 2022 Oct 1;71:116944. doi: 10.1016/j.bmc.2022.116944. Epub 2022 Jul 22. Bioorg Med Chem. 2022. PMID: 35917765

8

Oxytocin Dynamics in the Body and Brain Regulated by the Receptor for Advanced Glycation End-Products, CD38, CD157, and Nicotinamide Riboside.

Higashida H, Furuhara K, Lopatina O, Gerasimenko M, Hori O, Hattori T, Hayashi Y, Cherepanov SM, Shabalova AA, Salmina AB, Minami K, Yuhi T, Tsuji C, Fu P, Liu Z, Luo S, Zhang A, Yokoyama S, Shuto S, Watanabe M, Fujiwara K, Munesue SI, Harashima A, Yamamoto Y. Higashida H, et al. Among authors: shuto s. Front Neurosci. 2022 Jul 7;16:858070. doi: 10.3389/fnins.2022.858070. eCollection 2022. Front Neurosci. 2022. PMID: 35873827 Free PMC article. Review.

9

Design and Synthesis of Cyclopropane Congeners of Resolvin E3, an Endogenous Pro-Resolving Lipid Mediator, as Its Stable Equivalents.

Arai S, Fujiwara K, Kojima M, Aoki-Saito H, Yatomi M, Saito T, Koga Y, Fukuda H, Watanabe M, Matsunaga S, Hisada T, Shuto S. Arai S, et al. Among authors: shuto s. J Org Chem. 2022 Aug 5;87(15):10501-10508. doi: 10.1021/acs.joc.2c01110. Epub 2022 Jul 22. J Org Chem. 2022. PMID: 35866588

10

Synthesis of γ-Aminobutyric Acid (GABA) Analogues Conformationally Restricted by Bicyclo[3.1.0]hexane/hexene or [4.1.0]Heptane/heptene Backbones as Potent Betaine/GABA Transporter Inhibitors.

Mitsui K, Lie MEK, Saito N, Fujiwara K, Watanabe M, Wellendorph P, Shuto S. Mitsui K, et al. Among authors: shuto s. Org Lett. 2022 Jun 17;24(23):4151-4154. doi: 10.1021/acs.orglett.2c01346. Epub 2022 Jun 8. Org Lett. 2022. PMID: 35674784

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

178 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

178 results

Results by year